1 (053 50)
Pregabalin Capsule
Product Images NDC 73190-059
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 73190-059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (053 90)
This text provides information about a medication called Pregabalin Capsules, containing 25 mg of pregabalin. The usual dosage is advised to be taken with a meal. It also mentions storage instructions (at 20-25°C or 68-77°F) and further details like the manufacturer and contact information. The medication is dispensed in packages of 90 capsules.*
1 (054 50)
This is a description for Pregabalin Capsules G manufactured by AVKARE. Each capsule contains 50 mg of pregabalin, USP. It is important for the pharmacist to dispense the accompanying Medication Guide to each patient. The usual dosage can be found in the prescribing information. These capsules should be stored in a tight, child-resistant container at a temperature between 20° to 25°C (68° to 77°F). Manufacturing details are provided for AVKARE and ESKAYEF PHARMACEUTICALS LIMITED. For further inquiries, a toll-free number is provided: 1-855-361-3993.*
1 (054 90)
This text contains information about a medication called Pregabalin, which is available in capsules. The pharmacist is instructed to dispense a Medication Guide to each patient along with 90 capsules. The manufacturer is listed as ESKAYEF PHARMACEUTICALS LIMITED, located in Bangladesh. The text also mentions the phone number for the manufacturer's customer service. The usual dosage and storage instructions are provided.*
1 (055 50)
This is a description of AVKARE Pregabalin capsules containing 75 mg of pregabalin per capsule. It is recommended to dispense them in tight, child-resistant containers and to provide the accompanying medication guide to each patient. The usual dosage instructions and storage conditions are provided in the text. The medication is manufactured by Eskayef Pharmaceuticals Limited in Bangladesh and is distributed by AVKARE in Pulask, TN. For more information or assistance, a toll-free number is provided.*
1 (055 90)
1 (056 50)
This text is the label information for a medication called Pregaba in capsule form. Each capsule contains 100 mg of pregabalin, USP. The usual dosage information can be found in the accompanying prescribing information. The medication should be dispensed in tight, child-resistant containers and stored at a temperature between 20° to 25°C (68° to 77°F). The manufacturer is identified as ESKAYEF PHARMACEUTICALS LIMITED in Bangladesh. The label also includes a toll-free number for inquiries.*
1 (056 90)
1 (057 50)
This is a description of AVKARE Pregabalin capsules, each containing 150 mg of pregabalin. The usual dosage and storage instructions are provided. The medication guide should be dispensed to each patient along with the prescription. The capsules are to be dispensed in tight, child-resistant containers. The manufacturer is ESKAYEF Pharmaceuticals Limited in Bangladesh for AVKARE in Pulaski, TN. Contact information for AVKARE is given, including a toll-free number for assistance.*
1 (057 90)
1 (058 50)
This is a description of AVKARE Pregabalin Capsules containing 200mg of pregabalin USP. The capsules are meant for prescription use, with 500 capsules per container. Pharmacists are instructed to dispense them in tight, child-resistant containers and provide a Medication Guide to each patient. The Usual Dosage should be followed as per the accompanying prescribing information. The storage conditions require keeping the capsules at 20° to 25° C (68° to 77° F), with excursions permitted between 15° to 30° C (59° to 86° F). The manufacturer is listed as SK-F (ESKAYEF PHARMACEUTICALS LIMITED), located in Bangladesh. AVKARE, based in Pulaski, TN, is noted as the company the capsules are manufactured for. Customers can contact a toll-free number for inquiries.*
1 (058 90)
This text is a label for Pregabalin capsules with dosage information and storage instructions. It includes details such as the medication strength, manufacturer, usage guidance, and contact information for inquiries or assistance.*
1 (059 50)
This is a product label for pregabalin capsules by AVKARE. Each capsule contains 225 mg of pregabalin, USP. The usual dosage instructions can be found in the prescribing information provided. Pharmacists are instructed to dispense the medication guide with each patient. The capsules should be stored in a tight, child-resistant container at a temperature between 20° to 25° C (68° to 77° F). The manufacturer, SKF ESKAYEF PHARMACEUTICALS LIMITED, is based in Bangladesh. For inquiries or assistance, contact AVKARE in Pulaski, TN at the toll-free number provided.*
1 (059 90)
This is a product label for Pregabalin capsules, manufactured by SK-F. The usual dosage instructions and storage information are provided. The product comes in a package size of 90 capsules and the manufacturer's contact information is included. For more detailed information, refer to the accompanying prescribing information.*
1 (060 50)
This is a description of Pregabalin capsules containing 300 mg of Pregabalin. The recommended dosage and storage instructions are provided as well. The manufacturer is Eskayef Pharmaceuticals Limited located in Bangladesh. The medication guide must be dispensed to each patient along with the capsules.*
1 (060 90)
This is a description of a medication called Pregabalin in capsule form containing 300 mg of active ingredient. The text provides instructions for pharmacists to dispense the medication along with an accompanying Medication Guide to each patient. It also includes information on dosage, storage conditions, and the manufacturer details. The manufacturer is identified as Eskayef Pharmaceuticals Limited based in Bangladesh, and it was manufactured for Akare based in Pulasi, TN. Additionally, it mentions a toll-free number for inquiries.*
Chemical Structure (Pregabalin 01)
Figure 1 (Pregabalin 02)
This information shows the percentage of patients who experienced improvement in pain after taking different doses of Pregabalin and a placebo. The data indicates the level of pain improvement in relation to the baseline measurements.*
Figure 2 (Pregabalin 03)
This text provides data on the percentage of patients improved in pain after taking Pregabalin 100 mg three times a day compared to a placebo. The chart shows the percentage improvement in pain levels from baseline.*
Figure 3 (Pregabalin 04)
This text provides information on the percentage of patients improved after using different doses of pregabalin and placebo. The patients were treated with pregabalin at doses of 300mg two times a day, 150mg two times a day, and 75mg two times a day, as well as a placebo. The improvement in pain from baseline was also evaluated.*
Figure 4 (Pregabalin 05)
This text provides information about the percentage of patients improved with different dosages of pregabalin compared to a placebo in relation to the percentage improvement in pain from baseline. The dosages mentioned are 200 mg three times a day and 100 mg three times a day.*
Figure 5 (Pregabalin 06)
Figure 6 (Pregabalin 07)
Figure 7 (Pregabalin 08)
Figure 8 (Pregabalin 09)
This is a data table showing responder rates at different doses among respondents in a study. The responder rate is provided as percentages for each dose level. The table includes placebo and two different doses (2.5 mg/kg/day and 10 mg/kg/day) with corresponding respondent numbers.*
Figure 9 (Pregabalin 10)
Figure 10 (Pregabalin 11)
Not available.*
Figure 11 (Pregabalin 12)
This data shows the percentage of subjects who improved after taking either a placebo or Pregabalin. The text mentions percentages of 100, 90, and 80 for improvement. The improvement is tracked from baseline to week 12 using a method called BOCF.*
Figure 12 (Pregabalin 13)
This text provides data on the percentage of subjects who improved from baseline to week 16 in a study comparing Pregabalin to Placebo. The graph appears to show improvement percentages vs. values, with more details to be inferred from the provided numbers.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
